Animal models developed by researchers at IDIBELL and ICO can revolutionize the study of cancer

Orthotopic implants of human tumor tissues in mice behave similarly as tumors growing in humans

2012-10-09

(Press-News.org) Some animal models developed by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Catalan Institute of Oncology (ICO) has served to validate the effectiveness of a new drug against ovarian cancer resistant to cisplatin. The multidisciplinary work, done in collaboration with the biopharmaceutical company Pharmamar, was published in the journal Clinical Cancer Research.

The human tumor tissue is implanted in the same nude mouse organ from which it came. This type of implant, called orthotopic, can reproduce the histological, genetic and epigenetic human tumors and the patterns of tumor spread, which is not achieved with other methods of implementation. Furthermore, these tumor models will be keys to the development of the so-called personalized medicine against various cancers. Besides ovarian tumors, researchers are experienced in orthotopic implantation of other tumors such as colon, pancreas, breast, endometrial or testicle, and liver metastases and neurofibromatosis. Researchers are currently developing models of lung, head and neck tumors.

The technique has shown the effectiveness of lurbinectedin (PM01183), a drug recently approved by the Food and Drug Administration (FDA) as "orphan drug" against ovarian cancer. This disease is the fifth leading cause of death among women. The survival rate is very low because it is often diagnosed at an advanced stage and appear resistances to chemotherapy with cisplatin. So, it is necessary to find alternative treatments.

The lurbinectedin is a marine-derived drug developed by the pharmaceutical company Pharmamar, from the Zeltia group, which has been shown effective against ovarian tumors resistant to cisplatin in several studies. One of the most compelling studies in preclinical level is the work published now in Clinical Cancer Research. The article confirms that orthotopic implants in laboratory mice are useful not only to deepen the knowledge of tumors, but also to collaborate with the pharmaceutical industry in the process of developing new drugs to treat cancer. Lurbinectedin has recently demonstrated its efficacy in a Phase II study in treatment-resistant ovarian cancer.

The coordinator of the study and researcher at the IDIBELL and ICO, Alberto Villanueva, highlights the importance of the models developed in his laboratory that "allow obtaining tumors grown in mice that reproduce the immunohistochemical, genetic and epigenetic properties of the human tumors and its response to chemotherapy with cisplatin, that is the base of the treatment against ovarian cancer."

###Article reference

Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer. Vidal A, Munoz C, Guillen MJ, Moreto J, Sara P, Martinez-Iniesta M, Figueras A, Padulles L, Garcia-Rodriguez FJ, Berdiel-Acer M, Pujana MA, Salazar R, Gil-Martin M, Marti L, Ponce J, Mollevi DG, Capella G, Condom E, Vinals F, Huertas D, Cuevas C, Esteller M, Aviles P, Villanueva A. Clin Cancer Res. 2012 Aug 15. [Epub ahead of print]

ELSE PRESS RELEASES FROM THIS DATE:

MIT team builds most complex synthetic biology circuit yet

2012-10-09

CAMBRIDGE, MA -- Using genes as interchangeable parts, synthetic biologists design cellular circuits that can perform new functions, such as sensing environmental conditions. However, the complexity that can be achieved in such circuits has been limited by a critical bottleneck: the difficulty in assembling genetic components that don't interfere with each other. Unlike electronic circuits on a silicon chip, biological circuits inside a cell cannot be physically isolated from one another. "The cell is sort of a burrito. It has everything mixed together," says Christopher ...

Significant wheat production potential in 8 African nations-climate, soil and economic data analysis

2012-10-09

Julie-Anne Savarit-Cosenza 301-280-5720 julieanne@burnesscommunications.com International Maize and Wheat Improvement Center Ellen Wilson 301-280-5723 ewilson@burnesscommunications.com International Maize and Wheat Improvement Center Significant wheat production potential in 8 African nations-climate, soil and economic data analysis Researchers call for more research but comprehensive 12-country analysis suggests hungry region produces only 10% of possible wheat yield; could become more self-sufficient in wheat production as hedge against rising expensive ...

Can eating tomatoes lower the risk of stroke?

2012-10-09

MINNEAPOLIS – Eating tomatoes and tomato-based foods is associated with a lower risk of stroke, according to new research published in the October 9, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology. Tomatoes are high in the antioxidant lycopene. The study found that people with the highest amounts of lycopene in their blood were 55 percent less likely to have a stroke than people with the lowest amounts of lycopene in their blood. The study involved 1,031 men in Finland between the ages of 46 and 65. The level of lycopene ...

A new field of developmental neuroscience changes our understanding of the early years of human life

2012-10-09

Toronto – October 3, 2012. By the time our children reach kindergarten their learning and developmental patterns are already taking shape, as is a trajectory for their future health. Now, for the first time, scientists have amassed a large collection of research that looks "under the skin", to examine how and why experiences interact with biology starting before birth to affect a life course. Biological Embedding of Early Social Adversity: From Fruit Flies to Kindergartners, a special volume published in the Proceedings of the National Academy of Sciences and authored ...

Maternal depression affects language development in babies

2012-10-09

Maternal depression and a common class of antidepressants can alter a crucial period of language development in babies, according to a new study by researchers at the University of British Columbia, Harvard University and the Child & Family Research Institute (CFRI) at BC Children's Hospital. Published today in the Proceedings of the National Academy of Sciences, the study finds that treatment of maternal depression with serotonin reuptake inhibitors (SRIs) can accelerate babies' ability to attune to the sounds and sights of their native language, while maternal depression ...

Gladstone scientists discover gene 'bursting' plays key role in protein production

2012-10-09

SAN FRANCISCO, CA—October 8, 2012—Scientists at the Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes—and revealing new clues as to what happens when this process goes awry. In a study being published this week online in the Proceedings of the National Academy of Sciences, Gladstone Investigator Leor Weinberger, PhD, and his research team describe how a gene's on-and-off switching—called "bursting"—is the predominant method by which genes make ...

McGill researchers link genetic mutation to psychiatric disease and obesity

2012-10-09

McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity. The key lies in the genomic deletion of brain-derived neurotrophic factor, or BDNF, a nervous system growth factor that plays a critical role in brain development. To determine the role of BDNF in humans, Prof. Carl Ernst, from McGill's Department of Psychiatry, Faculty of Medicine, screened over 35,000 people referred for genetic screening at clinics and over 30,000 control subjects in Canada, the U.S., and Europe. Overall, ...

Health Canada's fast-tracked drug approvals can put public at risk

2012-10-09

TORONTO, October 4, 2012 – Drugs streamed into Health Canada's accelerated review process are more likely to be withdrawn from the market or earn a serious safety warning than those that undergo the standard review, according to a recent paper out of York University. The study, published online by the Archives of Internal Medicine on Oct. 8, is the first of its kind undertaken in Canada. It tracked a total of 434 new active substances (NASs) approved by Health Canada between 1995 and 2010, examining how many subsequently acquired either serious safety warnings or had ...

Learning from past flu epidemics to model outbreaks as they happen

2012-10-09

A new model of influenza transmission, published in BioMed Central's open access journal BMC Medicine, using more detailed information about patterns and severity of infection than previous models, finds that cases and transmission rates of H1N1 during the 2009-2010 flu pandemic have been underestimated. This model can provide a more robust and accurate real-time estimate of infection during a pandemic, which will help health services prepare and respond to future outbreaks. During an epidemic one of the most important pieces of information health services need in order ...

Maths adds new weapon in fight against pandemics

2012-10-09

Mathematicians have developed a powerful tool to quantify the spread and infectiousness of viruses like the pandemic H1N1 flu strain, which can be used together with modern laboratory techniques to help the healthcare system plan its response to disease outbreaks. By putting statistical data under the microscope, University of Warwick researchers have created a model to predict the impact of future pandemics in real-time as they strike. During the 2009 outbreak, the true extent of H1N1 was difficult to detect as in some people it caused severe symptoms, even death, whereas ...